Cornell inventors are turning visionary ideas into tangible solutions to global challenges. Cornell’s Center for Technology Licensing celebrated their achievements at its inaugural Bearers of Innovation event.
Women are at higher risk of death when undergoing heart bypass surgery than men, and researchers have determined that this disparity is mediated, to a large extent, by the loss of red blood cells during surgery.
Ashley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.
Since the spring of 2022, Cornell Law’s Appellate Criminal Defense Clinic, directed by Professor Rachel T. Goldberg, has provided students with the unique opportunity to oversee an entire appellate criminal case from start to finish.
A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.
Researchers developed a robotic version of a crash cart – a rolling storage cabinet stocked with medical supplies – to see if it can help out in unpredictable health care settings, like emergency and operating rooms.
The ILR School’s Climate Jobs Institute will share its new report, “Building an Equitable, Diverse and Unionized Clean Energy Economy: What We Can Learn from Apprenticeship Readiness,” at an in-person and online event on Nov. 30.
From inspiring lectures to thought-provoking exhibitions and much-anticipated renovations (plus the unveiling of the Dragon Annex), we're diving into a semester filled with opportunities not to be missed.
Twenty-four student teams have been selected for the Fall 2024 cohort of eLab, Cornell’s student startup accelerator. Now welcoming its 16th credit-bearing cohort, eLab accepts student founders from any field of study across Cornell and trains them to launch their businesses.
A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.